Supporting this hypothesis, mutations in the glucocerebrosidase 1 (GBA1) and synaptojanin 1 (SYNJ1) genes, which are involved in lipid metabolism, have been identified as risk factors for sPD and fPD, respectively. This evidence concerns the gene GBA1 and Platelet storage pool disease.